The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate‐specific antigen
Abstract
BACKGROUND: Sustained chronic inflammation in the prostate promotes prostate carcinogenesis. Since an elevated level of prostate‐specific antigen (PSA) per se reflects the presence of inflammation in the prostate, intervention to improve the PSA value might potentially have beneficial effects for the prevention of the development of prostate cancer. Isoflavones and curcumin have anti‐inflammatory and anti‐oxidant properties. We examined the biological effects of soy isoflavones and curcumin on LNCaP cells. After that, we conducted a clinical trial for men who received prostate biopsies, but were not found to have prostate cancer, to evaluate the effects of soy isoflavones and curcumin on serum PSA levels. METHODS: The expression of androgen receptor and PSA were examined in LNCaP cells before and after treatment of isoflavones and/or curcumin. Eighty‐five participants were randomized to take a supplement containing isoflavones and curcumin or placebo daily in a double‐blind study. Subjects were subdivided by the cut‐off of their baseline PSA value at 10 µg/ml. We evaluated values of PSA before and 6 months after treatment. RESULTS: The production of PSA were markedly decreased by the combined treatment of isoflavones and curcumin in prostate cancer cell line, LNCaP. The expression of the androgen receptor was also suppressed by the treatment. In clinical trials, PSA levels decreased in the patients group with PSA ≥ 10 treated with supplement containing isoflavones and curcumin (P = 0.01). CONCLUSIONS: Our results indicated that isoflavones and curcumin could modulate serum PSA levels. Curcumin presumably synergizes with isoflavones to suppress PSA production in prostate cells through the anti‐androgen effects. Prostate 70: 1127–1133, 2010. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Choi, Y. H., Lee, W. H., Park, K., & Zhang, L. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00928.x · Cited by 164
Cited by
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,110
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
Kunnumakkara, A. B., Bordoloi, D., Padmavathi, G., Monisha, J., Roy, N. K., Prasad, S., & Aggarwal, B. B. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13621 · Cited by 1,053
A Review of Curcumin and Its Derivatives as Anticancer Agents
Tomeh, M. A., Hadianamrei, R., & Zhao, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051033 · Cited by 949
Natural Polyphenols for Prevention and Treatment of Cancer
Zhou, Y., Zheng, J., Li, Y., Xu, D.-P., Li, S., Chen, Y.-M., & Li, H.-B. (2016) · Nutrients · doi:10.3390/nu8080515 · Cited by 746
Gupta, S. C., Hevia, D., Patchva, S., Park, B., Koh, W., & Aggarwal, B. B. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4414 · Cited by 732
Anticancer Efficacy of Polyphenols and Their Combinations
Niedzwiecki, A., Roomi, M., Kalinovsky, T., & Rath, M. (2016) · Nutrients · doi:10.3390/nu8090552 · Cited by 538
Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature
Messina, M. (2016) · Nutrients · doi:10.3390/nu8120754 · Cited by 537
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
The therapeutic potential of curcumin: A review of clinical trials
Salehi, B., Stojanović-Radić, Z., Matejić, J., Sharifi-Rad, M., Anil Kumar, N. V., Martins, N., & Sharifi-Rad, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.016 · Cited by 495
Curcumin, a component of turmeric: From farm to pharmacy
Gupta, S. C., Kismali, G., & Aggarwal, B. B. (2013) · BioFactors · doi:10.1002/biof.1079 · Cited by 396
Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers
Aggarwal, B. B., Gupta, S. C., & Sung, B. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12131 · Cited by 395
Clinical effects of curcumin in enhancing cancer therapy: A systematic review
Mansouri, K., Rasoulpoor, S., Daneshkhah, A., Abolfathi, S., Salari, N., Mohammadi, M., Rasoulpoor, S., & Shabani, S. (2020) · BMC Cancer · doi:10.1186/s12885-020-07256-8 · Cited by 386
Ma, Z., Wang, N., He, H., & Tang, X. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.053 · Cited by 345
Curcumin mediates anticancer effects by modulating multiple cell signaling pathways
Kunnumakkara, A. B., Bordoloi, D., Harsha, C., Banik, K., Gupta, S. C., & Aggarwal, B. B. (2017) · Clinical Science · doi:10.1042/cs20160935 · Cited by 332
El-Saadony, M. T., Yang, T., Korma, S. A., Sitohy, M., Abd El-Mageed, T. A., Selim, S., Al Jaouni, S. K., Salem, H. M., Mahmmod, Y., Soliman, S. M., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1040259 · Cited by 330
Schiborr, C., Kocher, A., Behnam, D., Jandasek, J., Toelstede, S., & Frank, J. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300724 · Cited by 321
Antiviral potential of curcumin
Mathew, D., & Hsu, W.-L. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2017.12.017 · Cited by 258
Cancer cell signaling pathways targeted by spice-derived nutraceuticals
Sung, B., Prasad, S., Yadav, V. R., & Aggarwal, B. B. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.630551 · Cited by 204
Metadata
- Authors
- Ide, H., Tokiwa, S., Sakamaki, K., Nishio, K., Isotani, S., Muto, S., Hama, T., Masuda, H., & Horie, S.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2010-03-26
- Volume
- 70
- Issue
- 10
- Pages
- 1127-1133
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2077584435
- Cited by
- 181
- References
- 1
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.